Parker Waichman LLP

JAMA Study: Januvia, Byetta Double Risks for Pancreatitis

Prior research revealed that Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Now, a new study finds that the drugs may double patients’ risks for developing pancreatitis. Although linked to pancreatitis in prior research, the new study, […]

jama-study-Januvia-Byetta-Double-RisksPrior research revealed that Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Now, a new study finds that the drugs may double patients’ risks for developing pancreatitis.

Although linked to pancreatitis in prior research, the new study, published by JAMA Internal Medicine, was able to provide numbers for that increased risk, said FiercePharma. Januvia and Byetta are sold through a Merck and Bristol-Myers Squibb/AstraZeneca collaboration. Pancreatitis is an inflammation of the pancreas that is linked to cancer and kidney failure, Bloomberg.com explained.

Study author, Sonal Singh, assistant professor at Johns Hopkins University, and colleagues, reviewed insurance records and found that patients hospitalized with pancreatitis experienced a two-fold risk of being diagnosed with the disease if they had taken Januvia or Byetta, when compared to diabetics who did not have pancreatitis, said FiercePharma. The study looked at 1,268 diabetics hospitalized with pancreatitis and 1,268 patients diagnosed with pancreatitis, but who did not have diabetes, explained Bloomberg.com. Of the pancreatitis patients, 87 had filled a prescription for Byetta or Januvia; in the control group, 58 control filled similar prescriptions. “This is the first real study to give an estimate of what the risk is,” said Singh. “ntil now we just had a few case reports,” he added.

Approved in 2006 by the U.S. Food & Drug Administration (FDA), Januvia continues to be associated with risks for pancreatic side effects, pancreatitis, and pancreatic cancer. In 2009, the agency required a label update warning of the risk of acute pancreatitis based on 88 reports of acute pancreatitis in patients who took Januvia between October 2006 and February 2009. Chronic pancreatitis is painful, potentially fatal, and a known risk factor for pancreatic cancer. Byetta, administered via a twice-daily injection, was first approved in 2005 to be used in conjunction with other diabetes treatments and was later approved as a stand-alone therapy for Type 2 diabetes.

Testing for the safety of Januvia has not looked at other effects drugs in the DPP-4 inhibitors class, specifically, the drugs’ role in inhibiting one of the body’s natural cancer-suppressing mechanisms. For example, diabetes patients could be at risk for years before the full effects and risks of taking Januvia and other DPP-4 drugs are known. Amylin Pharmaceuticals came under fire for allegedly hiding a study that revealed serious heart risks associated with Byetta. FDA claimed Amylin concealed the Byetta heart study from the agency, and then tried to keep the FDA from getting its hands on the key data when the agency learned of its existence.

As we’ve explained, both drugs are glucagon-like peptide-1 (GLP-1) based therapies that are in the class dipeptidyl peptidase-4 (DPP-4) inhibitors. The drugs increase certain natural substances that lower raised blood sugar levels. Diabetics typically have abnormally low amount insulin levels or their bodies have difficulties utilizing insulin efficiently. “These drugs are effective in lower glucose, but we should also consider the risk of pancreatitis and balance the risk versus the benefit,” said Singh.

Pancreatitis occurs in about three in every 1,000 diabetes patients. Should that risk double in patients taking Byetta or Januvia, the number would rise to six in every 1,000 patients, said Singh. In the United States, about 8.6 percent of the population—25 million people—were diagnosed with diabetes in 2010, based on Bloomberg.com data. That number is expected to rise to more than 34 million by 2020.

We recently wrote that researchers at the University of California, Los Angeles looked at both Januvia and Byetta in comparison to other therapies and all of the drugs’ risks for pancreatic and thyroid cancers and pancreatitis. The study, published in the journal, Gastroenterology, was conducted by researchers at the University of California and revealed that Januvia and Byetta patients experienced a nearly three-fold risk of developing pancreatic cancer. Evidence also suggests an increased incidence of thyroid cancer among patients taking Byetta.

Other serious side effects have been linked to these Type 2 diabetes drugs including, low blood sugar; anaphylaxis and other allergic reactions including hives, rash, swelling of face, lips, tongue, and/or throat; acute pancreatitis, and death.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I don't have enough words to describe my experience with Parker Waichman LLP Lawyers and its staff. So much gratitude to Ashley Lopilato, who worked with me in my case. Throughout the process, she was very professional, knowledgeable, always kept me updated, and patient with all my questions. Her expertise professionalism supersedes my expectations. I highly recommend Parker Waichman LLP. to my friends and family.
Libarbara Vargas
2 years ago
5 Star Reviews 150
I was truly blessed to work with the Law Firm of PW Parker/ Waichman LLP to resolve a claim.I was assigned to work with one of their Paralegals by the name of Benita Rollins. I would like to say it was a pleasure and honor to work with this individual who had a willingness and eagerness to always be of assistance and answer any questions or concerns I had. Ms. Rollins would always make herself available as needed and follow up with me as needed. I would recommend this firm to anyone who may need legal advice because I believe you are in great hands. Ms. Devalerie Robinson
Valerie Robinson
2 years ago
5 Star Reviews 150
I contacted Parker Waichman a little over 2 years ago in regards to a WTC claim. PW informed me, at that time, that I had to register with the WTC Health Plan. Well, this led to 2 years of patience, health exams and time (on both my part and PW's part) to have my health conditions certified. Directly following certification, Nicole Copertino quickly pushed my claim through with diligence and expert professionalism. I truly appreciate her care and concern for me. I look forward to a positive outcome. Duly note her expertise and talent. Thank You Nicole. Looking forward to working with you through to the outcome.
Lee Pinckney
9 months ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038